The development of animal models of bipolar disorder (BD) is a challenge by its complicated
clinical course, which involves mania, depression, mixed states, and euthymia. Most
animal models of BD focus on inducing mania- or depression-like behavior individually.
The intracerebroventricular administration of ouabain is an example of a pharmacological
model, which has been increasingly explored in the study of BD.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Biological PsychiatryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2020 Published by Elsevier Inc.
